1. Home
  2. MSA vs KYMR Comparison

MSA vs KYMR Comparison

Compare MSA & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MSA Safety Incorporated

MSA

MSA Safety Incorporated

HOLD

Current Price

$181.20

Market Cap

6.4B

Sector

Health Care

ML Signal

HOLD

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

HOLD

Current Price

$70.12

Market Cap

6.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MSA
KYMR
Founded
1914
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4B
6.4B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
MSA
KYMR
Price
$181.20
$70.12
Analyst Decision
Buy
Strong Buy
Analyst Count
4
24
Target Price
$185.25
$105.35
AVG Volume (30 Days)
229.1K
682.9K
Earning Date
02-11-2026
02-26-2026
Dividend Yield
1.16%
N/A
EPS Growth
3.07
N/A
EPS
7.10
N/A
Revenue
$1,863,597,000.00
$43,735,000.00
Revenue This Year
$4.58
$18.70
Revenue Next Year
$5.61
N/A
P/E Ratio
$25.83
N/A
Revenue Growth
3.31
N/A
52 Week Low
$127.86
$19.45
52 Week High
$185.54
$103.00

Technical Indicators

Market Signals
Indicator
MSA
KYMR
Relative Strength Index (RSI) 65.35 42.21
Support Level $179.25 $66.21
Resistance Level $185.54 $72.86
Average True Range (ATR) 3.80 3.68
MACD 0.90 -0.76
Stochastic Oscillator 81.22 29.99

Price Performance

Historical Comparison
MSA
KYMR

About MSA MSA Safety Incorporated

MSA Safety Inc makes safety products that are used to protect workers in the oil and gas and mining industries. The products include breathing apparatuses, fall protection, portable gas detection systems, industrial head protection, fire and rescue helmets, and fixed gas and flame detection systems. End markets include the fire service, contractor, industrial, mining, oil and gas, and utilities industries. The company's reportable geographic segments are Northern North America; Latin America; Europe, Middle East & Africa; and Asia Pacific. The company's operating segments have been aggregated into three reportable segments: Americas, International, and Corporate. Geographically the company generates the majority of its revenue from the United States.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

Share on Social Networks: